Abstract
Purpose
To relate the concept of the retinal neurovascular unit and its alterations in diabetes to the pathophysiology of diabetic retinopathy.
Methods
Case illustrations and conceptual frameworks are presented that illustrate adaptive and maladaptive “dis-integration” of the retinal neurovascular unit with the progression of diabetes.
Results
Retinopathy treatment should address pathophysiologic processes rather than pathologic lesions as is current practice.
Conclusions
Future improvements in the treatment of diabetic retinopathy requires deeper understanding of the cellular and molecular changes induced by diabetes, coupled with the use of quantitative phenotyping methods that assess the pathophysiologic processes.
Similar content being viewed by others
References
Hawkins BT, Davis TP (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173–185
Metea MR, Newman EA (2007) Signalling within the neurovascular unit in the mammalian retina. Exp Physiol 92:635–640
Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227–1239
Lott ME, Slocomb JE, Shivkumar V, Smith B, Gabbay RA, Quillen D, Gardner TW, Bettermann K (2012) Comparison of retinal vasodilator and constrictor responses in type 2 diabetes. Acta Ophthalmol 90:e434–e441
Pemp B, Garhofer G, Weigert G, Karl K, Resch H, Wolzt M, Schmetterer L (2009) Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes. Invest Ophthalmol Vis Sci 50:4029–4032
Newman EA (2015) Glial cell regulation of neuronal activity and blood flow in the retina by release of gliotransmitters. Philos Trans R Soc Lond B Biol Sci 370
Aung MH, Park HN, Han MK, Obertone TS, Abey J, Aseem F, Thule PM, Iuvone PM, Pardue MT (2014) Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes. J Neurosci 34:726–736
Gastinger MJ, Kunselman AR, Conboy EE, Bronson SK, Barber AJ (2008) Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. Invest Ophthalmol Vis Sci 49:2635–2642
D’Cruz TS, Weibley BN, Kimball SR, Barber AJ (2012) Post-translational processing of synaptophysin in the rat retina is disrupted by diabetes. PLoS ONE 7:e44711
Barber AJ, Gardner TW, Abcouwer SF (2011) The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 52:1156–1163
Lieth E, LaNoue KF, Antonetti DA, Ratz M, Group, T.P.S.R.R. (2000) Diabetes reduces glutamate oxidation and glutamine synthesis in the retina. Exp Eye Res 70:723–730
Pannicke T, Iandiev I, Wurm A, Uckermann O, vom Hagen F, Reichenbach A, Wiedemann P, Hammes HP, Bringmann A (2006) Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina. Diabetes 55:633–639
Barber AJ, Antonetti DA, Gardner TW (2000) Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest Ophthalmol Vis Sci 41:3561–3568
Karlstetter M, Scholz R, Rutar M, Wong WT, Provis JM, Langmann T (2015) Retinal microglia: just bystander or target for therapy? Prog Retin Eye Res 45:30–57
Reiter CEN, Wu X, Sandirasegarane L, Nakamura M, Gilbert KA, Singh RSJ, Fort PE, Antonetti DA, Gardner TW (2006) Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin. Diabetes 55:1148–1156
Harrison WW, Bearse MA Jr, Ng JS, Jewell NP, Barez S, Burger D, Schneck ME, Adams AJ (2011) Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. Invest Ophthalmol Vis Sci 52:772–777
Fort PE, Losiewicz MK, Pennathur S, Jefferson LS, Kimball SR, Abcouwer SF, Gardner TW (2014) mTORC1-independent reduction of retinal protein synthesis in type 1 diabetes. Diabetes 63:3077–3090
Fox TE, Han X, Kelly S, Merrill AH Jr, Martin RE, Anderson RE, Gardner TW, Kester M (2006) Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy. Diabetes 55:3573–3580
Tikhonenko M, Lydic TA, Wang Y, Chen W, Opreanu M, Sochacki A, McSorley KM, Renis RL, Kern T, Jump DB et al (2010) Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes 59:219–227
Piano I, Novelli E, Della Santina L, Strettoi E, Cervetto L, Gargini C (2016) Involvement of autophagic pathway in the progression of retinal degeneration in a mouse model of diabetes. Front Cell Neurosci 10:42
Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M (1998) Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339:69–75
Gray EJ, Gardner TW (2015) Retinal failure in diabetes: a feature of retinal sensory neuropathy. Curr Diab Rep 15
Simonsen SE (1969) ERG in juvenile diabetics: a prognostic study. In: Goldberg MF, Fine SL (eds) Symposium on the treatment of diabetic retinopathy. US Department of Health, Education and Welfare, Arlington, pp 681–689
Bresnick GH, Korth K, Groo A, Palta M (1984) Electroretinographic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report. Arch Ophthalmol 102:1307–1311
Jackson GR, Scott IU, Quillen DA, Walter LE, Gardner TW (2012) Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy. Br J Ophthalmol 96:699–703
Orlov S, Cherney DZ, Pop-Busui R, Lovblom LE, Ficociello LH, Smiles AM, Warram JH, Krolewski AS, Perkins BA (2015) Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes. Clin J Am Soc Nephrol 10:1136–1144
Qian Y, Feldman E, Pennathur S, Kretzler M, Brosius FC 3rd (2008) From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 57:1439–1445
Bek T (1994) Transretinal histopathological changes in capillary-free areas of diabetic retinopathy. Acta Ophthalmol 72:409–415
Dodo Y, Murakami T, Uji A, Yoshitake S, Yoshimura N (2015) Disorganized retinal lamellar structures in nonperfused areas of diabetic retinopathy. Invest Ophthalmol Vis Sci 56:2012–2020
Sun JK, Lin MM, Lammer J, Prager S, Sarangi R, Silva PS, Aiello LP (2014) Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol 132:1309–1316
Sun JK, Radwan SH, Soliman AZ, Lammer J, Lin MM, Prager SG, Silva PS, Aiello LB, Aiello LP (2015) Neural retinal disorganization as a robust marker of visual acuity in current and resolved diabetic macular edema. Diabetes 64:2560–2570
Scarinci F, Jampol LM, Linsenmeier RA, Fawzi AA (2015) Association of diabetic macular nonperfusion with outer retinal disruption on optical coherence tomography. JAMA Ophthalmol 133:1036–1044
Mazhar K, Varma R, Choudhury F, McKean-Cowdin R, Shtir CJ, Azen SP, Los Angeles Latino Eye Study, G (2011) Severity of diabetic retinopathy and health-related quality of life: the Los Angeles Latino Eye Study. Ophthalmology 118:649–655
Sohn EH, van Dijk HW, Jiao C, Kok PH, Jeong W, Demirkaya N, Garmager A, Wit F, Kucukevcilioglu M, van Velthoven ME et al (2016) Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci U S A 113:E2655–E2664
Acknowledgments
This work was supported by R01EY20582, DP3DK094292, P30EY007003, The Taubman Institute, and Research to Prevent Blindness, and previously by the Jack and Nancy Turner Professorship at Penn State University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gardner, T.W., Davila, J.R. The neurovascular unit and the pathophysiologic basis of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 255, 1–6 (2017). https://doi.org/10.1007/s00417-016-3548-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-016-3548-y